MSDS

01/20/2014
EN (English)
2/7
Sakrete Masonry Coating: 34% of the mixture consists of ingredient(s) of unknown acute toxicity.
Sakrete Surface Bonding Cement (Gray/White): 25% of the mixture consists of ingredient(s) of unknown acute toxicity.
Sakrete Non-Shrink Construction Grout: 24% of the mixture consists of ingredient(s) of unknown acute toxicity.
Sakrete Stone Veneer Mortar: 18% of the mixture consists of ingredient(s) of unknown acute toxicity.
Sakrete Mortar-Stucco Mix Type S (Gray): 14% of the mixture consists of ingredient(s) of unknown acute toxicity.
Sakrete Mortar-Stucco Mix Type S (White): 12% of the mixture consists of ingredient(s) of unknown acute toxicity.
Sakrete Mortar Mix Type N: 13% of the mixture consists of ingredient(s) of unknown acute toxicity.
Not applicable.
Name
Product identifier
%
GHS-US classification
Quartz
(CAS No) 14808-60-7
30 - 85
Acute Tox. 4 (Oral), H302
Carc. 1A, H350
STOT RE 1, H372
Cement, portland, chemicals
(CAS No) 65997-15-1
5 - 55
Skin Irrit. 2, H315
Eye Dam. 1, H318
Skin Sens. 1, H317
STOT SE 3, H335
Limestone
(CAS No) 1317-65-3
0.5 - 17
Not classified
Calcium magnesium hydroxide (CaMg(OH)4)
(CAS No) 39445-23-3
1 - 5
1
Skin Irrit. 2, H315
Eye Dam. 1, H318
STOT SE 3, H335
Calcium magnesium hydroxide oxide (CaMg(OH)2O)
(CAS No) 58398-71-3
1 - 5
1
Not classified
Gypsum (Ca(SO4).2H2O)
(CAS No) 13397-24-5
0.5 - 5
Not classified
Calcium hydroxide
(CAS No) 1305-62-0
0.5 - 5
1
Skin Corr. 1B, H314
Eye Dam. 1, H318
Calcium sulfate
(CAS No) 7778-18-9
0.5 - 5
Not classified
Calcium oxide
(CAS No) 1305-78-8
0.5 - 2
Acute Tox. 4 (Oral), H302
Skin Irrit. 2, H315
Eye Dam. 1, H318
STOT SE 3, H335
Cement, alumina, chemicals
(CAS No) 65997-16-2
1 - 5
2
Skin Irrit. 2, H315
Eye Dam. 1, H318
1
Sakrete Mortar/Stucco Mix Type S (White); Sakrete Masonry Coating
2
Sakrete Fast Setting Concrete Mix; Sakrete Non-Shrink Construction Grout
The exact percentage (concentration) of composition has been withheld as a trade secret in accordance with paragraph (i) of ยง1910.1200.
First-aid measures after inhalation
:
If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for
breathing. Get medical advice/attention if you feel unwell.
First-aid measures after skin contact
:
In case of contact, immediately flush skin with plenty of water. Remove contaminated clothing
and shoes. Wash clothing before reuse. Call a physician if irritation develops and persists.
First-aid measures after eye contact
:
In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. If easy to
do, remove contact lenses, if worn. Get medical attention immediately.
First-aid measures after ingestion
:
If swallowed, do NOT induce vomiting unless directed to do so by medical personnel. Never give
anything by mouth to an unconscious person. Immediately call a POISON CENTER or
doctor/physician.
Symptoms/injuries after inhalation
:
May cause respiratory tract irritation.
Symptoms/injuries after skin contact
:
Causes skin irritation. May cause burns in the presence of moisture. Skin contact during
hydration may slowly develop sufficient heat that may cause severe burns possibly resulting in
permanent injury. Do not allow product to harden around any body part or allow continuous,
prolonged contact with skin. Handling can cause dry skin. May cause sensitization by skin
contact.
Symptoms/injuries after eye contact
:
Causes serious eye damage. May cause burns in the presence of moisture. Symptoms may
include discomfort or pain, excess blinking and tear production, with possible redness and
swelling.
Symptoms/injuries after ingestion
:
Harmful if swallowed. May cause stomach distress, nausea or vomiting.
Symptoms may not appear immediately. In case of accident or if you feel unwell, seek medical advice immediately (show the label or SDS where
possible).
4.3. Indication of any immediate medical attention and special treatment needed
4.2. Most important symptoms and effects, both acute and delayed
4.1. Description of first aid measures
SECTION 4: First aid measures
3.2. Mixture
3.1. Substances
SECTION 3: Composition/information on ingredients
2.4. Unknown acute toxicity (GHS US)